214 related articles for article (PubMed ID: 20957343)
1. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test.
Gjesing AP; Kjems LL; Vestmar MA; Grarup N; Linneberg A; Deacon CF; Holst JJ; Pedersen O; Hansen T
Diabetologia; 2011 Jan; 54(1):103-10. PubMed ID: 20957343
[TBL] [Abstract][Full Text] [Related]
2. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
Pilgaard K; Jensen CB; Schou JH; Lyssenko V; Wegner L; Brøns C; Vilsbøll T; Hansen T; Madsbad S; Holst JJ; Vølund A; Poulsen P; Groop L; Pedersen O; Vaag AA
Diabetologia; 2009 Jul; 52(7):1298-307. PubMed ID: 19288077
[TBL] [Abstract][Full Text] [Related]
3. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
[TBL] [Abstract][Full Text] [Related]
4. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele.
Færch K; Pilgaard K; Knop FK; Hansen T; Pedersen O; Jørgensen T; Holst JJ
Diabetes Obes Metab; 2013 Jan; 15(1):91-5. PubMed ID: 22862926
[TBL] [Abstract][Full Text] [Related]
5. Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146 TCF7L2 Gene Variant.
Daniele G; Gaggini M; Comassi M; Bianchi C; Basta G; Dardano A; Miccoli R; Mari A; Gastaldelli A; Del Prato S
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1160-7. PubMed ID: 26046964
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between TCF7L2 gene polymorphism and genetic susceptibility in women with gestational diabetes mellitus].
Shi X; Cai Q; Zou M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):588-93. PubMed ID: 25354859
[TBL] [Abstract][Full Text] [Related]
7. Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes.
Ferreira MC; da Silva MER; Fukui RT; do Carmo Arruda-Marques M; Azhar S; Dos Santos RF
Diabetol Metab Syndr; 2019; 11():10. PubMed ID: 30700996
[TBL] [Abstract][Full Text] [Related]
8. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Regul Pept; 2003 Jul; 114(2-3):115-21. PubMed ID: 12832099
[TBL] [Abstract][Full Text] [Related]
9. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
[TBL] [Abstract][Full Text] [Related]
10.
Ferreira MC; da Silva MER; Fukui RT; Arruda-Marques MDC; Dos Santos RF
Diabetol Metab Syndr; 2018; 10():37. PubMed ID: 29736187
[TBL] [Abstract][Full Text] [Related]
11. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
Meier JJ; Nauck MA; Kranz D; Holst JJ; Deacon CF; Gaeckler D; Schmidt WE; Gallwitz B
Diabetes; 2004 Mar; 53(3):654-62. PubMed ID: 14988249
[TBL] [Abstract][Full Text] [Related]
12. Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon-like peptide 1.
Silbernagel G; Renner W; Grammer TB; Hügl SR; Bertram J; Kleber ME; Hoffmann MM; Winkelmann BR; März W; Boehm BO
Diabetes Metab Res Rev; 2011 Jul; 27(5):499-505. PubMed ID: 21384500
[TBL] [Abstract][Full Text] [Related]
13. GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals.
Gasbjerg LS; Helsted MM; Hartmann B; Sparre-Ulrich AH; Veedfald S; Stensen S; Lanng AR; Bergmann NC; Christensen MB; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32077470
[TBL] [Abstract][Full Text] [Related]
14. Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group.
Shokouhi S; Delpisheh A; Haghani K; Mahdizadeh M; Bakhtiyari S
Clin Lab; 2014; 60(8):1269-76. PubMed ID: 25185411
[TBL] [Abstract][Full Text] [Related]
15. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice.
da Silva Xavier G; Mondragon A; Sun G; Chen L; McGinty JA; French PM; Rutter GA
Diabetologia; 2012 Oct; 55(10):2667-2676. PubMed ID: 22717537
[TBL] [Abstract][Full Text] [Related]
16. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
[TBL] [Abstract][Full Text] [Related]
17. Glucose tolerance and free fatty acid metabolism in adults with variations in TCF7L2 rs7903146.
Lu J; Varghese RT; Zhou L; Vella A; Jensen MD
Metabolism; 2017 Mar; 68():55-63. PubMed ID: 28183453
[TBL] [Abstract][Full Text] [Related]
18. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
19. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
20. Association between the rs7903146 Polymorphism in the TCF7L2 Gene and Parameters Derived with Continuous Glucose Monitoring in Individuals without Diabetes.
van der Kroef S; Noordam R; Deelen J; Akintola AA; Jansen SW; Postmus I; Wijsman CA; Beekman M; Mooijaart SP; Slagboom PE; van Heemst D
PLoS One; 2016; 11(2):e0149992. PubMed ID: 26914832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
